MedinCell S.A. (MEB.F)
MedinCell S.A., a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France.
26.00+0.04%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+68.2%
The outlook
MedinCell S.A. currently reads as leaning bullish based on above its 50- & 200-day averages, 48% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range48% of the way from its 52-week low to high
Market cap
$933.7M
52-wk high
37.82
52-wk low
15.04
50-day avg
25.96
200-day avg
25.46
Trailing P/E
—